Correlation Between Microsoft and Raphael Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Microsoft and Raphael Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Raphael Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and Raphael Pharmaceutical, you can compare the effects of market volatilities on Microsoft and Raphael Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Raphael Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Raphael Pharmaceutical.
Diversification Opportunities for Microsoft and Raphael Pharmaceutical
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Microsoft and Raphael is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Raphael Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Raphael Pharmaceutical and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Raphael Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Raphael Pharmaceutical has no effect on the direction of Microsoft i.e., Microsoft and Raphael Pharmaceutical go up and down completely randomly.
Pair Corralation between Microsoft and Raphael Pharmaceutical
Given the investment horizon of 90 days Microsoft is expected to generate 0.12 times more return on investment than Raphael Pharmaceutical. However, Microsoft is 8.11 times less risky than Raphael Pharmaceutical. It trades about 0.05 of its potential returns per unit of risk. Raphael Pharmaceutical is currently generating about -0.12 per unit of risk. If you would invest 40,862 in Microsoft on September 2, 2024 and sell it today you would earn a total of 1,484 from holding Microsoft or generate 3.63% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 98.46% |
| Values | Daily Returns |
Microsoft vs. Raphael Pharmaceutical
Performance |
| Timeline |
| Microsoft |
| Raphael Pharmaceutical |
Microsoft and Raphael Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Microsoft and Raphael Pharmaceutical
The main advantage of trading using opposite Microsoft and Raphael Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Raphael Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Raphael Pharmaceutical will offset losses from the drop in Raphael Pharmaceutical's long position.| Microsoft vs. Palo Alto Networks | Microsoft vs. Uipath Inc | Microsoft vs. Block Inc | Microsoft vs. Adobe Systems Incorporated |
| Raphael Pharmaceutical vs. BBB Foods | Raphael Pharmaceutical vs. Zedge Inc | Raphael Pharmaceutical vs. Bridgford Foods | Raphael Pharmaceutical vs. Space Communication |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |